Pierre Vidailhet
A5058645154- Schizophrenia research and treatment
- Mental Health and Psychiatry
- Psychosomatic Disorders and Their Treatments
- Tryptophan and brain disorders
- COVID-19 and Mental Health
- Bipolar Disorder and Treatment
- Memory Processes and Influences
- Mental Health Treatment and Access
- Memory and Neural Mechanisms
- Neural and Behavioral Psychology Studies
- Functional Brain Connectivity Studies
- Neurological disorders and treatments
- Epilepsy research and treatment
- Health Systems, Economic Evaluations, Quality of Life
- Posttraumatic Stress Disorder Research
- Treatment of Major Depression
- Healthcare professionals’ stress and burnout
- Pharmaceutical studies and practices
- Parkinson's Disease Mechanisms and Treatments
- Psychoanalysis and Psychopathology Research
- Stress Responses and Cortisol
- Child and Adolescent Psychosocial and Emotional Development
- Attention Deficit Hyperactivity Disorder
- Pharmaceutical Practices and Patient Outcomes
- Nicotinic Acetylcholine Receptors Study
Université de Strasbourg
2015-2024
Inserm
2011-2024
Hôpital Civil, Strasbourg
2004-2024
Neuroscience et Psychiatrie Translationnelle de Strasbourg
2024
Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie
2011-2023
Hôpitaux Universitaires de Strasbourg
2011-2023
Fondation FondaMental
2015-2022
Hôpital Albert-Chenevier
2016-2022
Université Paris-Est Créteil
2020
Centre Hospitalier de Versailles
2015-2019
Abstract Background The acknowledgment of the mental health toll COVID-19 epidemic in healthcare workers has increased considerably as disease evolved into a pandemic status. Indeed, high prevalence rates depression, sleep disorders, and post-traumatic stress disorder (PTSD) have been reported Chinese during peak. Symptoms psychological distress are expected to be long-lasting systemic impact on systems, warranting need for evidence-based treatments aiming at relieving immediate preventing...
COVID-19 long-haulers, also decribed as having "long-COVID" or post-acute syndrome, represent 10% of patients and remain understudied. In this prospective study, we recruited 30 consecutive seeking medical help for persistent symptoms (> days) attributed to COVID-19. All reported a viral illness compatible with The underwent multi-modal evaluation, including clinical, psychologic, virologic specific immunologic assays were followed longitudinally. A group 17 convalescent individuals without...
Abstract Objective To compare the clinical symptomatology in patients with Early‐Onset Schizophrenia (EOS, N = 176), especially subgroup Very Early Onset (VEOS) and Adult (AOS, 551). Method In a large French multicentric sample, 727 stable schizophrenia patients, classified by age at onset of disorder, were assessed using standardized extensive neuropsychological batteries: AOS ≥ 18 years EOS < (including 22 VEOS 13 years). Results The importance better diagnosing group, particularly...
Suicidal behaviour and deliberate self-harm are common among adults. Research indicates that maintaining contact either via letter or postcard with at-risk adults following discharge from care services can reduce reattempt risk. Feasibility trials demonstrated intervention through text message was also effective in preventing suicide repetition amongst attempters. The aim of the current study is to investigate effect versus traditional treatment on reducing risk attempt after self-harm. will...
In this prospective multicentre, open-label, 6-month study (Paliperidone Palmitate Flexible Dosing in Schizophrenia [PALMFlexS]), tolerability, safety and treatment response with paliperidone palmitate (PP) were explored patients acute symptoms of schizophrenia following switching from previously unsuccessful oral antipsychotics. This pragmatic was conducted a large, more representative sample the general population compared to randomized controlled pivotal trials, specifically mimic...
Major depressive disorder (MDD) is underdiagnosed and undertreated in schizophrenia, has been strongly associated with impaired quality of life.AimsTo determine the prevalence factors MDD unremitted to compare treated non-treated MDD.Participants were included FondaMental Expert Centers for Schizophrenia received a thorough clinical assessment. was defined by Calgary score ≥6. Non-remitted current antidepressant treatment (unchanged >8 weeks) ≥6.613 patients 175 (28.5%) identified MDD....
Abstract Treatment-resistant schizophrenia (TRS) affects around 30% of patients with (SZ) resulting in poor functioning, relapses, and reduced quality life. Convergent findings show that inflammation could contribute to resistance. We thus search for immune signatures TRS/ultra TRS (UTRS) a sample community-dwelling outpatients SZ. In total, 195 stabilized SZ (mean age = 31.2 years, 73% male gender) were consecutively included the network FondaMental Expert Centers Schizophrenia France...
Abstract Purpose Studies of mental illness stigma reduction interventions have been criticised for failing to evaluate behavioural outcomes and mechanisms action. This project evaluates training medical students entitled ‘Responding Experienced Anticipated Discrimination’ (READ), developed focus on skills in addition attitudes knowledge. We aimed (i) the effectiveness READ with respect knowledge, attitudes, clinical communication responding illness-related discrimination, (ii) investigate...
Healthcare workers' mental health has been impacted by the COVID-19 pandemic, emphasizing need for interventions in this population. Online cognitive behavioral therapy (CBT) is efficient to reduce stress and may reach numerous professionals. We developed "MyHealthToo", an online CBT program help among healthcare workers during pandemic.